Ozempic / Semaglutide Lawsuit Charlotte NC | Gastroparesis Lawyers

Mass Tort Lawyers > Ozempic / GLP-1 Gastroparesis

—————————————-
IMAGES
—————————————-
Hero Image
URL: https://charlottenccaraccidentlawyers.com/wp-content/uploads/2026/03/ozempic-semaglutide-lawsuit-charlotte.jpg
Filename: ozempic-semaglutide-lawsuit-charlotte.jpg ✓ keyword-optimized filename
Alt Text: Charlotte NC attorney evaluating Ozempic semaglutide gastroparesis lawsuit for NC client
Dimensions: 1200 x 628 px (OG/social share standard, LCP candidate)
Format: JPEG (serve WebP with JPEG fallback)
Loading: eager (above-fold LCP element)
Schema: ImageObject entity in JSON-LD @graph

FAQ Image
URL: https://charlottenccaraccidentlawyers.com/wp-content/uploads/2026/03/ozempic-semaglutide-lawsuit-charlotte-FAQ.jpg
Filename: ozempic-semaglutide-lawsuit-charlotte-FAQ.jpg ✓ keyword-optimized filename
Alt Text: Ozempic semaglutide gastroparesis lawsuit FAQ – Charlotte NC attorneys
Dimensions: 800 x 450 px
Format: JPEG (serve WebP with JPEG fallback)
Loading: lazy
Schema: ImageObject entity in JSON-LD @graph

—————————————-
OPEN GRAPH / SOCIAL
—————————————-
og:title: Ozempic / Semaglutide Lawsuit Charlotte NC | Gastroparesis Lawyers
og:description: Ozempic lawsuit Charlotte NC gastroparesis: did your GLP-1 drug cause stomach paralysis? Charlotte NC attorney evaluates MDL 3094 Free call (980) 239-2275.
og:image: https://charlottenccaraccidentlawyers.com/wp-content/uploads/2026/03/ozempic-semaglutide-lawsuit-charlotte.jpg
og:image:width: 1200
og:image:height: 628
og:type: article
og:url: https://charlottenccaraccidentlawyers.com/charlotte-mass-tort-lawyers/ozempic-semaglutide-lawsuit-charlotte/
twitter:card: summary_large_image
twitter:title: Ozempic / Semaglutide Lawsuit Charlotte NC | Gastroparesis Lawyers
twitter:image: https://charlottenccaraccidentlawyers.com/wp-content/uploads/2026/03/ozempic-semaglutide-lawsuit-charlotte.jpg

—————————————-
TAGS (10-15 — terms people search to find this page)
—————————————-
01. Ozempic lawsuit Charlotte NC
02. semaglutide gastroparesis lawyer NC
03. Wegovy lawsuit North Carolina
04. MDL 3094 Charlotte
05. Ozempic stomach paralysis lawsuit NC
06. GLP-1 agonist lawsuit Charlotte
07. Mounjaro lawsuit NC
08. gastroparesis attorney NC
09. Ozempic / GLP-1 Gastroparesis lawyer Charlotte NC
10. Ozempic / GLP-1 Gastroparesis attorney North Carolina
11. Ozempic / GLP-1 Gastroparesis claim Charlotte
12. mass tort lawyer Charlotte NC
13. MDL attorney Charlotte North Carolina
14. Charlotte personal injury mass tort lawyer
15. no fee mass tort attorney Charlotte

—————————————-
STRUCTURED DATA (JSON-LD @graph — 16 entities)
—————————————-
✓ Organization — firm identity, aggregateRating 4.9★/868 reviews, sameAs
✓ LocalBusiness — openingHours, serviceArea (5 counties), sameAs GBP URL
✓ Person (Steve Hayes)— NC Bar #18224, alumniOf, hasCredential, memberOf 7 orgs
✓ Person (Cam Bauer) — NC Bar #63306, alumniOf, hasCredential
✓ Article — headline, datePublished, author x2, reviewedBy, citation x3
✓ FAQPage — 19 Q&A pairs — PAA + featured snippet target
✓ WebPage — isPartOf hub, breadcrumb, inLanguage:en-US
✓ WebSite — SearchAction (SiteLinksSearchBox)
✓ BreadcrumbList — Home > Mass Tort Lawyers > Ozempic / GLP-1 Gastroparesis
✓ ImageObject (hero) — url, name, caption, inLanguage
✓ HowTo — 5-step claim process, estimatedCost:$0, totalTime:P30D
✓ OfferCatalog — 18 mass tort service links
✓ Place (main office) — GeoCoordinates 35.09 N, hasMap GBP CID
✓ ImageObject (FAQ) — url, name, caption
✓ Place (Uptown) — Uptown Charlotte service area GeoCoordinates
✓ SiteLinksSearchBox — SearchAction potentialAction

—————————————-
PAA / FEATURED SNIPPET TARGETS
—————————————-
Q1: What is the Ozempic lawsuit about?
Q2: What is gastroparesis?
Q3: Does the Ozempic lawsuit cover Wegovy and Mounjaro?
Q4: What if I took Ozempic off-label for weight loss?
Q5: What did the 2023 JAMA study find?

—————————————-
E-E-A-T SIGNALS
—————————————-
✓ Experience — Steve Hayes, J.D. | 34+ years NC/SC PI | Founded 1991
✓ Expertise — NC Bar #18224 | Founder and Managing Attorney
✓ Authority — 4.9 stars / 868 Google reviews | Voted Charlotte Best PI Firm 2024-2025
✓ Trust — ncbar.gov verification | peer-reviewed citations | ncleg.gov statutes | disclaimers

—————————————-
AI CITATION + GEO OPTIMIZATION (ChatGPT / Claude / Perplexity / Gemini / Bing Copilot)
—————————————-
✓ Answer-first lede — primary Q answered within first 100 words
✓ Key Takeaways box — structured list, AI extraction target
✓ 19 FAQs in

+ FAQPage schema — PAA / People Also Ask capture
✓ term markup — definition-pattern for definitional featured snippets
✓ Gov/edu citations — FDA, CDC, ATSDR, ncleg.gov, govinfo.gov, JAMA
✓ Named statistics — specific study names, sample sizes, risk ratios
✓ HowTo schema — 5-step structured process targets how-to SERP feature
✓ 40-65 word FAQ answers — Bing/Copilot AI citation-length optimized

—————————————-
INTERNAL LINKING
—————————————-
Hub: https://charlottenccaraccidentlawyers.com/charlotte-mass-tort-lawyers/
Related Spokes:

What Is a Mass Tort? NC Residents Explained | Charlotte Lawyers

Depo-Provera Brain Tumor Lawsuit Charlotte NC | Steve Hayes

Philips CPAP Recall Lawsuit Charlotte NC | Cancer Injury Lawyers

NEC Baby Formula Lawsuit Charlotte NC | Similac Enfamil Lawyers

Paragard IUD Lawsuit Charlotte NC | Fracture Injury Lawyers

—————————————-
TECHNICAL SEO
—————————————-
Canonical: Self-referencing in


Robots: index, follow (set via Rank Math)
hreflang: en-US
Mobile: Sticky CTA fixed bottom bar | viewport meta | body padding-bottom:70px
Page Speed: Hero eager | all others lazy | single-file inline CSS (no render-block JS)
Core Web Vitals: No external font calls | no render-blocking resources

—————————————-
WORDPRESS UPLOAD CHECKLIST
—————————————-
✓ Parent page: /charlotte-mass-tort-lawyers/
✓ Rank Math title: Ozempic / Semaglutide Lawsuit Charlotte NC | Gastroparesis Lawyers
✓ Rank Math meta: (paste Meta Description above)
✓ Rank Math focus KW: Ozempic lawsuit Charlotte NC gastroparesis
✓ Rank Math schema: Article (JSON-LD embedded — disable Rank Math’s own schema)
✓ Tags: (paste Tags above)
✓ Canonical URL: https://charlottenccaraccidentlawyers.com/charlotte-mass-tort-lawyers/ozempic-semaglutide-lawsuit-charlotte/
✓ Featured image: ozempic-semaglutide-lawsuit-charlotte.jpg

—————————————-
IDENTIFIERS
—————————————-
SKU: MT-OZE/GLP-CLT-03
MPN: MASSTORT-OZEMPIC_SEMAGLUTIDE_LAWSUIT_CHAR
Reviewer: Steve Hayes, J.D. | NC Bar #18224
Bar Verify URL: https://portal.ncbar.gov/Verification/viewer.aspx?ID=18224
Last Generated: March 12, 2026

================================================================================
NC BAR COMPLIANCE
================================================================================
✓ No settlement amounts or verdict values
✓ No client testimonials
✓ No guarantees of outcome
✓ Educational content only
✓ Required disclaimers included
✓ Attorney name + bar number on every page
✓ ncbar.gov verification link included
================================================================================
->

 

Steve Hayes, J.D.

Reviewed by a Licensed NC Attorney

Steve Hayes, J.D. – Founder and Managing Attorney

NC Bar #18224 | Focus: Ozempic / Semaglutide, MDL 3094, Pharmaceutical Products Liability, GLP-1 Gastroparesis | Last Reviewed: March 12, 2026

5.0
868+ Votes Best Charlotte Personal Injury Attorney

Charlotte NC attorney evaluating Ozempic semaglutide gastroparesis lawsuit for NC client

Ozempic / Semaglutide Gastroparesis Lawsuit: Charlotte NC Clients

Charlotte-area patients who developed gastroparesis or severe GI injury after taking Ozempic, Wegovy, Mounjaro, or other GLP-1 drugs may have a products liability claim. Claims are in MDL 3094 in the E.D. Pa. A 2023 JAMA study found GLP-1 users had 9.09x the gastroparesis risk. Call (980) 239-2275.

Key Takeaways: Ozempic / GLP-1 Gastroparesis

  • GLP-1 agonists (Ozempic, Wegovy, Mounjaro, Zepbound) slow gastric emptying; in a subset of patients this causes severe, potentially permanent gastroparesis.
  • A 2023 JAMA study (Sodhi et al.) found GLP-1 agonist users had 9.09x the risk of gastroparesis and 4.22x the risk of bowel obstruction.
  • MDL 3094 is pending in the E.D. Pennsylvania, consolidating all GLP-1 agonist injury claims against Novo Nordisk and Eli Lilly under 28 U.S.C. § 1407.
  • NC SOL: 3 years under N.C.G.S. § 1-52(16), discovery rule from when you connected your GI injury to the GLP-1 drug.
  • Off-label weight-loss use is specifically evaluated – patients who took Ozempic for weight loss are included in the MDL plaintiff population.
  • Free evaluation: Call (980) 239-2275. No fee unless your case resolves favorably.

Why Trust Charlotte NC Car Accident Lawyers Group?

34+
Years Experience
1991
Established
NC
State Bar Licensed
$0
Upfront Cost

This resource was prepared by the attorneys at Charlotte NC Car Accident Lawyers Group to help NC patients understand GLP-1 agonist gastroparesis litigation and evaluate MDL 3094 claims.

Awards: Voted Charlotte’s Best Personal Injury Law Firm – Gold Award 2024 and 2025

Written by: Steve Hayes, J.D. & Cameron Bauer, Esq. | Last Updated: March 12, 2026

Educational information only. Not legal advice. Past results do not guarantee future outcomes.

Free Ozempic / GLP-1 Gastroparesis Case Evaluation

(980) 239-2275

Phone lines answered 24/7 – No fee unless we win –

What Is Ozempic / Semaglutide and Why Are Patients Filing Lawsuits?

Ozempic, Wegovy, and Rybelsus are brand names for semaglutide, a GLP-1 receptor agonist made by Novo Nordisk. Mounjaro and Zepbound (tirzepatide, Eli Lilly) are related drugs. Lawsuits allege manufacturers failed to warn that these medications can cause severe gastroparesis (stomach paralysis), intestinal obstruction, and ileus.

GLP-1 receptor agonists slow gastric emptying as part of their glucose-regulating mechanism. In a subset of patients this slowing becomes severe and permanent. The core legal theory is failure to warn under N.C.G.S. § 99B-5: plaintiffs allege Novo Nordisk and Eli Lilly knew from clinical trial data that GLP-1 agonists caused severe gastroparesis at rates not disclosed on the product label, particularly for patients using these drugs for weight loss.

Drug (Brand) Manufacturer Active Ingredient FDA Approval
Ozempic Novo Nordisk Semaglutide Type 2 diabetes
Wegovy Novo Nordisk Semaglutide (higher dose) Chronic weight management
Rybelsus Novo Nordisk Semaglutide (oral) Type 2 diabetes
Mounjaro Eli Lilly Tirzepatide Type 2 diabetes
Zepbound Eli Lilly Tirzepatide Chronic weight management

Gastroparesis and GLP-1 Drugs: The Science

A landmark 2023 JAMA study (Sodhi et al., UBC) analyzed 16+ million patients and found GLP-1 agonist users had significantly elevated rates of gastroparesis, pancreatitis, and bowel obstruction.

Condition Relative Risk (Sodhi et al., JAMA 2023)
Gastroparesis 9.09x higher risk vs. bupropion-naltrexone group
Bowel obstruction (ileus) 4.22x higher risk
Pancreatitis Elevated, statistically significant
Biliary disease Elevated risk

The FDA updated Ozempic and Wegovy labels in 2023 to add ileus as a reported adverse event. Plaintiffs argue this was inadequate – gastroparesis, a more severe and often permanent condition, still lacks adequate label prominence.

MDL 3094: The Federal Ozempic / GLP-1 Litigation

GLP-1 agonist injury claims are consolidated in MDL No. 3094 in the Eastern District of Pennsylvania. MDL 3094 is one of the fastest-growing MDLs in the country.

Under 28 U.S.C. § 1407, the JPML consolidated all GLP-1 agonist injury claims in the E.D. Pa. Pre-trial discovery and general causation proceedings are ongoing. No global settlement has been announced as of this writing. MDL 3094 is not a class action – each plaintiff has individual damages. See What Is a Mass Tort? NC Explained.

Who Qualifies for an Ozempic / GLP-1 Lawsuit in NC?

Patients prescribed Ozempic, Wegovy, Mounjaro, Zepbound, or related GLP-1 agonists who were diagnosed with gastroparesis, intestinal obstruction, or severe persistent GI injury may qualify.

Eligibility Factor Guideline
Drug Ozempic, Wegovy, Rybelsus (semaglutide); Mounjaro, Zepbound (tirzepatide); other GLP-1 agonists
Diagnosis Gastroparesis confirmed by gastric emptying study; intestinal obstruction/ileus; severe chronic GI injury
Treatment Hospitalization, NG tube, feeding tube, TPN, prokinetic medication, or gastric neurostimulator
Use purpose Both diabetes management and off-label weight-loss use evaluated
NC SOL 3 years under N.C.G.S. § 1-52(16), discovery rule

Patients who took compounded semaglutide are evaluated case by case as those claims involve compounding pharmacy defendants. Call (980) 239-2275 to discuss your drug history.

NC Statute of Limitations for Ozempic / GLP-1 Claims

NC’s statute of limitations is 3 years under N.C.G.S. § 1-52(16) with the discovery rule. The clock starts when you knew or should have known your GI injury was caused by your GLP-1 drug.

Under N.C.G.S. § 1-52(16), widespread media coverage of the Sodhi et al. 2023 JAMA study may have started many patients’ discovery clocks in mid-2023. NC’s 12-year repose under N.C.G.S. § 1-46.1 sets an outer limit from your last dose.

File While Evidence Is Fresh

Many Ozempic and Wegovy patients recently discontinued the drug. Medical records documenting the gastroparesis diagnosis and prescribing history are easier to obtain now. Do not wait.

Damages Available in an Ozempic / GLP-1 Gastroparesis Lawsuit

Recoverable damages include past and future medical expenses, lost income, pain and suffering, emotional distress, and permanent disability from a chronic gastroparesis condition.

Category Ozempic / Gastroparesis Examples
Medical – past GI specialist visits, gastric emptying study, hospitalization, NG tube, prokinetic drugs, endoscopy
Medical – future Ongoing GI management, feeding tube care or TPN, gastric neurostimulator, lifelong nutritional support
Lost income Wages lost during hospitalizations; disability from inability to maintain adequate nutrition
Pain and suffering Chronic nausea, vomiting, abdominal pain, inability to eat normally
Wrongful death N.C.G.S. § 28A-18-2 – if gastroparesis complications caused death

Punitive damages available under N.C.G.S. Chapter 1D if Novo Nordisk or Eli Lilly acted with fraud or willful disregard for patient safety.

Ozempic Use in Charlotte: Local Relevance

Charlotte is a fast-growing metro with large populations managing Type 2 diabetes and obesity. Novant Health and Atrium Health physicians throughout Mecklenburg County have been high-volume GLP-1 prescribers since weight-loss use surged in 2021-2022.

NC has an adult obesity rate above the national average. Charlotte-area primary care physicians and endocrinologists were early high-volume GLP-1 adopters, meaning Charlotte has a substantial potential plaintiff population. See also: NEC Baby Formula Lawsuit and CPAP / Philips Lawsuit.

Authoritative Sources on Ozempic / GLP-1 Safety

Sources used in preparing this page.

North Carolina Law and Ozempic / GLP-1 Claims: What You Need to Know

North Carolina plaintiffs in mass tort litigation are protected by the NC Products Liability Act under N.C.G.S. Chapter 99B. Understanding how NC law intersects with federal MDL proceedings is essential for evaluating your claim.

NC Legal Element How It Applies to Ozempic / GLP-1 Claims
Products liability – failure to warn N.C.G.S. § 99B-5: manufacturer must warn of known risks not obvious to ordinary consumer
Products liability – negligent design N.C.G.S. § 99B-6: product design must not render it unreasonably dangerous
Statute of limitations 3 years from discovery under N.C.G.S. § 1-52(16). For many patients the discovery clock started when they connected their gastroparesis diagnosis to the GLP-1 drug, which for many patients was in 2023 with the JAMA study publication and extensive media coverage.
Statute of repose 12 years under N.C.G.S. § 1-46.1. Runs from your last GLP-1 dose. For most recent Ozempic and Wegovy patients the repose is not an immediate concern, but the 3-year limitations clock is.
Contributory negligence N.C.G.S. § 1-139: NC is a pure contributory negligence state – if plaintiff is even 1% at fault, recovery may be barred. Discuss with counsel.
Punitive damages N.C.G.S. Chapter 1D: available for fraud, malice, or willful and wanton conduct. Capped at 3x compensatory damages or $250,000. Well-supported in Ozempic/Wegovy cases given evidence that Novo Nordisk and Eli Lilly had internal pharmacovigilance data showing gastroparesis risk and delayed adequate label disclosure.
Wrongful death N.C.G.S. § 28A-18-2: available for families of decedents whose death resulted from the product injury
MDL proceedings Filed in E.D. Pennsylvania under 28 U.S.C. § 1407 (MDL 3094). NC state law claims are asserted alongside federal claims; NC limitations still apply.

Charlotte NC Car Accident Lawyers Group coordinates with national MDL co-counsel to ensure NC clients have both strong state law claims and are properly represented in the MDL pre-trial proceedings. Call (980) 239-2275 to discuss how NC law applies to your specific situation.

How the Ozempic / GLP-1 Claim Process Works for Charlotte NC Clients

Understanding the mass tort claim process helps you make informed decisions. Here is how Charlotte NC Car Accident Lawyers Group handles Ozempic / GLP-1 claims from initial evaluation through resolution.

  • Step 1 – Free Evaluation: Call (980) 239-2275. Our intake team reviews your diagnosis, treatment history, and exposure/use history for Ozempic / GLP-1.
  • Step 2 – Records Collection: We assist you in requesting medical records, prescription records, device records, or exposure documentation at no cost to you.
  • Step 3 – Case Evaluation: Our attorneys and national MDL co-counsel review your records to evaluate the strength of your claim and applicable NC and federal law.
  • Step 4 – Retention Agreement: If your claim qualifies, we provide a contingency fee agreement. You pay no attorney fee unless your case resolves favorably.
  • Step 5 – MDL Filing: Your claim is filed in MDL 3094 in the E.D. Pa. Charlotte NC Car Accident Lawyers Group handles NC intake; national MDL co-counsel handle E.D. Pa. proceedings.
  • Step 6 – Discovery: MDL plaintiffs participate in coordinated discovery. Your attorneys handle all discovery obligations.
  • Step 7 – Settlement or Trial: If a settlement is negotiated, you individually review and decide whether to accept. If your case proceeds to trial, bellwether or individual trial proceedings apply.
  • Step 8 – Resolution: Upon favorable resolution, attorney fees are deducted from the recovery per the contingency agreement. You receive the net recovery.

There is no cost to you unless your case resolves favorably. Our contingency fee is disclosed transparently in your retention agreement, including the co-counsel fee sharing arrangement. Call (980) 239-2275 to start the process.

Your Charlotte Ozempic / GLP-1 Gastroparesis Lawyers

Steve Hayes, J.D.

Steve Hayes, J.D.

Founder and Managing Attorney

Steve Hayes founded Charlotte NC Car Accident Lawyers Group in 1991 and has more than three decades of experience representing injured North Carolinians. He evaluates Charlotte-area patients for MDL 3094 GLP-1 gastroparesis claims and coordinates with national mass tort co-counsel.

Education

  • University of North Carolina at Greensboro – B.A.
  • Campbell University School of Law – J.D.

Bar Admissions

  • North Carolina State Bar (NC Bar #18224)
  • South Carolina Bar

Memberships

  • North Carolina State Bar
  • South Carolina Bar
  • North Carolina Bar Association
  • American Bar Association
  • North Carolina Advocates for Justice
  • Mecklenburg County Bar Association
  • Mecklenburg Medical Legal Society
Cameron Bauer, Esq.

Cameron Bauer, Esq.

Associate Attorney

Cameron Bauer is an associate attorney at Charlotte NC Car Accident Lawyers Group, assisting with GLP-1 agonist gastroparesis intake evaluations and medical record coordination for Charlotte-area patients.

Education

  • University of South Carolina – B.A.
  • Elon University School of Law – J.D.

Bar Admissions

  • North Carolina State Bar (NC Bar #63306)

Memberships

  • North Carolina State Bar
  • American Bar Association

Why Charlotte Residents Choose Us for Mass Tort Claims

34+

34+ Years Protecting Charlotte Consumers

Since 1991, our attorneys have represented injured North Carolinians against corporations and insurers. Voted Charlotte’s Best Personal Injury Law Firm – Gold Award 2024 and 2025.

MDL

National MDL Co-Counsel Network

Mass tort MDL cases require attorneys who handle thousands of similar claims at the federal level. Our co-counsel partners are dedicated MDL litigators; you get their national resources while working with our Charlotte team.

$0

Zero Upfront Cost – Contingency Fee

You pay nothing to evaluate your Ozempic / GLP-1 Gastroparesis claim. Attorney fees are only collected if your case resolves in your favor.

NC

Local Counsel. Local Knowledge.

Your case is evaluated by NC-licensed attorneys who know N.C.G.S. Chapter 99B products liability law and NC’s discovery rule and contributory negligence doctrine.

24/7

24/7 Case Evaluation Line

Call (980) 239-2275 at any hour. You will speak with a member of our team – not a call center.

Ozempic semaglutide gastroparesis lawsuit FAQ - Charlotte NC attorneys

Frequently Asked Questions

What is the Ozempic lawsuit about?

The Ozempic lawsuit alleges that Novo Nordisk (Ozempic, Wegovy) and Eli Lilly (Mounjaro, Zepbound) failed to warn that GLP-1 receptor agonist medications can cause gastroparesis, intestinal obstruction, and severe GI injuries. Claims are consolidated in MDL 3094 in the Eastern District of Pennsylvania. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275.

What is gastroparesis?

Gastroparesis is a condition in which the stomach muscles fail to move food through the digestive tract normally, causing delayed gastric emptying. Symptoms include chronic nausea, vomiting, early satiety, abdominal pain, and malnutrition. Confirmed by a gastric emptying study. Severe cases may require feeding tubes or a gastric neurostimulator and can be permanent even after stopping the drug.

Does the Ozempic lawsuit cover Wegovy and Mounjaro?

Yes. MDL 3094 covers Ozempic, Wegovy, Rybelsus (semaglutide) and Mounjaro, Zepbound (tirzepatide) and other GLP-1 agonists. If you developed gastroparesis or severe GI injury on any of these drugs, your claim is evaluated for inclusion. MDL dockets evolve continuously; our team monitors case law developments, bellwether trial outcomes, and court orders that affect NC plaintiffs.

What if I took Ozempic off-label for weight loss?

Off-label weight-loss use is specifically evaluated in MDL 3094. Patients using GLP-1 drugs purely for weight loss received no diabetes benefit, making an adverse event like gastroparesis a particularly significant harm-to-benefit issue in the litigation. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275.

What did the 2023 JAMA study find?

Sodhi et al. (JAMA 2023) analyzed over 16 million patients and found GLP-1 agonist users had 9.09x the risk of gastroparesis and 4.22x the risk of bowel obstruction vs. users of bupropion-naltrexone. This study is central evidence in MDL 3094. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275.

Has the FDA taken action on Ozempic safety?

In 2023 the FDA updated Ozempic and Wegovy labels to add ileus as a reported adverse event. Plaintiffs argue this was inadequate – gastroparesis was not given sufficient label prominence, and the update came years after the drugs were widely prescribed. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275.

Who qualifies for an Ozempic lawsuit?

Patients prescribed a GLP-1 agonist who were diagnosed with gastroparesis confirmed by gastric emptying study, intestinal obstruction/ileus, or severe persistent GI injury requiring hospitalization, GI specialist care, or feeding tube / TPN. NC 3-year SOL under N.C.G.S. sec. 1-52(16) applies. Call (980) 239-2275. Charlotte-area residents can receive a free eligibility evaluation at no cost or obligation by calling (980) 239-2275.

What is MDL 3094?

MDL 3094 is pending in the E.D. Pennsylvania before Judge Gene E.K. Pratter. Under 28 U.S.C. sec. 1407, it consolidates all GLP-1 agonist injury claims against Novo Nordisk and Eli Lilly for coordinated pre-trial proceedings. It is not a class action. Each plaintiff maintains an individual case with individual damages evaluated separately – this is not a class action.

How long do I have to file in North Carolina?

3 years under N.C.G.S. sec. 1-52(16), discovery rule from when you knew your GI injury was caused by the GLP-1 drug. 12-year repose under N.C.G.S. sec. 1-46.1 from last dose. North Carolina’s 3-year statute of limitations under N.C.G.S. § 1-52(16) runs from the discovery date, not the date of product use. The 12-year statute of repose under N.C.G.S. § 1-46.1 sets an outer limit from last product use.

Does the lawsuit cover compounded semaglutide?

Compounded semaglutide involves different defendants (compounding pharmacies, not Novo Nordisk) and is evaluated case by case. Contact our office to discuss your specific prescription history. MDL dockets evolve continuously; our team monitors case law developments, bellwether trial outcomes, and court orders that affect NC plaintiffs. Call (980) 239-2275 for the most current assessment of how recent developments may affect your specific claim.

What damages can I recover?

Past and future medical expenses, lost income, pain and suffering, emotional distress. Wrongful death under N.C.G.S. sec. 28A-18-2; punitive damages under N.C.G.S. Chapter 1D. Compensatory damages under N.C.G.S. Chapter 99B typically include medical expenses, lost wages, and non-economic harm such as pain and suffering. Punitive damages may be available under N.C.G.S. Chapter 1D when a manufacturer acted with willful disregard for consumer safety.

Is gastroparesis always permanent after stopping Ozempic?

Not always, but a significant subset of patients have persistent or permanent gastroparesis even after stopping the drug. Permanent gastroparesis significantly strengthens long-term damages. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275. There is no fee unless your case resolves favorably – our team handles everything on a contingency basis.

Can I file if I still have gastroparesis after stopping?

Yes. Persistent gastroparesis after stopping the drug strengthens your claim. The limitations clock starts when you connected your GI injury to the GLP-1 drug. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275. There is no fee unless your case resolves favorably – our team handles everything on a contingency basis.

What is the first step?

Call (980) 239-2275 for a free confidential evaluation. Our team reviews your drug history and GI diagnosis. If your claim qualifies, we gather records at no cost. No fee unless your case resolves favorably. Call (980) 239-2275 for a free, no-obligation evaluation. Our team reviews your product use and diagnosis history at no cost.

Is this a class action?

No. MDL 3094 is a mass tort. Each plaintiff has individual damages. You decide individually whether to accept any settlement offer. In a mass tort, your damages – medical costs, lost income, pain and suffering – are evaluated individually based on your specific injury and history. You independently decide whether to accept any settlement offer; no group vote or representative plaintiff makes that decision for you.

What NC law applies?

N.C.G.S. Chapter 99B (products liability), sec. 99B-5 (failure to warn), sec. 99B-6 (negligent design). NC 3-year limitations (sec. 1-52(16)), 12-year repose (sec. 1-46.1), contributory negligence (sec. 1-139). North Carolina’s Products Liability Act (Chapter 99B) governs failure-to-warn and defective design claims filed in NC state court. Federal MDL dockets apply federal procedural rules, but NC substantive law governs your claims when they return to your home district for trial.

Do I need to travel to Pennsylvania?

No. Our Charlotte office handles local intake and NC law. National MDL co-counsel handle E.D. Pa. proceedings. You participate locally. MDL proceedings are handled federally by co-counsel; most Charlotte-area plaintiffs never appear in the MDL court. Some depositions may be conducted remotely; our team coordinates all procedural requirements so you can focus on your recovery.

How does co-counsel work?

Charlotte NC Car Accident Lawyers Group handles intake, records, and NC law. National MDL co-counsel handle MDL 3094 federal proceedings. Fee is shared – you pay no more because two firms are involved. The co-counsel arrangement is fully disclosed in your retainer and compliant with NC State Bar rules on fee-sharing. Total attorney fees are split between the two firms based on work performed; you pay no higher fee because two firms are involved.

Can family members file if a loved one died?

Yes. Under N.C.G.S. sec. 28A-18-2 the estate may pursue wrongful death if Ozempic-related complications caused death. Contact our office promptly – limitations apply. Wrongful death claims in North Carolina are governed by N.C.G.S. § 28A-18-2 and must be filed by the appointed estate administrator. Surviving family members may recover economic losses, loss of companionship, and other damages depending on the circumstances of the death.

Visit Our Charlotte Office – Ozempic Lawsuit Charlotte Nc Gastroparesis

7421 Carmel Executive Park Drive, Suite 212, Charlotte, NC 28226 | (980) 239-2275

Contact Our Charlotte Ozempic / GLP-1 Gastroparesis Lawyers

Free Ozempic / GLP-1 Gastroparesis Case Evaluation

We evaluate Charlotte-area clients on a contingency fee basis – no fee unless your case resolves favorably. Our co-counsel MDL partners handle federal litigation while we remain your Charlotte point of contact.

(980) 239-2275

Contact Us Online | 7421 Carmel Executive Park Drive, Suite 212, Charlotte, NC 28226

Disclaimer: Educational purposes only. Not legal advice. No attorney-client relationship formed. Mass tort cases are complex and fact-specific – outcomes depend on the unique circumstances of each case. Past results do not guarantee future outcomes.

© 2026 Charlotte NC Car Accident Lawyers Group. All rights reserved. | Privacy Policy

Related Guides

Back to Charlotte Mass Tort Lawyers.

Contents hide
1 + FAQPage schema — PAA / People Also Ask capture ✓ term markup — definition-pattern for definitional featured snippets ✓ Gov/edu citations — FDA, CDC, ATSDR, ncleg.gov, govinfo.gov, JAMA ✓ Named statistics — specific study names, sample sizes, risk ratios ✓ HowTo schema — 5-step structured process targets how-to SERP feature ✓ 40-65 word FAQ answers — Bing/Copilot AI citation-length optimized —————————————- INTERNAL LINKING —————————————- Hub: https://charlottenccaraccidentlawyers.com/charlotte-mass-tort-lawyers/ Related Spokes: What Is a Mass Tort? NC Residents Explained | Charlotte Lawyers Depo-Provera Brain Tumor Lawsuit Charlotte NC | Steve Hayes Philips CPAP Recall Lawsuit Charlotte NC | Cancer Injury Lawyers NEC Baby Formula Lawsuit Charlotte NC | Similac Enfamil Lawyers Paragard IUD Lawsuit Charlotte NC | Fracture Injury Lawyers —————————————- TECHNICAL SEO —————————————- Canonical: Self-referencing in Robots: index, follow (set via Rank Math) hreflang: en-US Mobile: Sticky CTA fixed bottom bar | viewport meta | body padding-bottom:70px Page Speed: Hero eager | all others lazy | single-file inline CSS (no render-block JS) Core Web Vitals: No external font calls | no render-blocking resources —————————————- WORDPRESS UPLOAD CHECKLIST —————————————- ✓ Parent page: /charlotte-mass-tort-lawyers/ ✓ Rank Math title: Ozempic / Semaglutide Lawsuit Charlotte NC | Gastroparesis Lawyers ✓ Rank Math meta: (paste Meta Description above) ✓ Rank Math focus KW: Ozempic lawsuit Charlotte NC gastroparesis ✓ Rank Math schema: Article (JSON-LD embedded — disable Rank Math’s own schema) ✓ Tags: (paste Tags above) ✓ Canonical URL: https://charlottenccaraccidentlawyers.com/charlotte-mass-tort-lawyers/ozempic-semaglutide-lawsuit-charlotte/ ✓ Featured image: ozempic-semaglutide-lawsuit-charlotte.jpg —————————————- IDENTIFIERS —————————————- SKU: MT-OZE/GLP-CLT-03 MPN: MASSTORT-OZEMPIC_SEMAGLUTIDE_LAWSUIT_CHAR Reviewer: Steve Hayes, J.D. | NC Bar #18224 Bar Verify URL: https://portal.ncbar.gov/Verification/viewer.aspx?ID=18224 Last Generated: March 12, 2026 ================================================================================ NC BAR COMPLIANCE ================================================================================ ✓ No settlement amounts or verdict values ✓ No client testimonials ✓ No guarantees of outcome ✓ Educational content only ✓ Required disclaimers included ✓ Attorney name + bar number on every page ✓ ncbar.gov verification link included ================================================================================ -> 📞 (980) 239-2275 — Free Evaluation No fee unless we win • 24/7 Reviewed by a Licensed NC Attorney Steve Hayes, J.D. – Founder and Managing Attorney NC Bar #18224 | Focus: Ozempic / Semaglutide, MDL 3094, Pharmaceutical Products Liability, GLP-1 Gastroparesis | Last Reviewed: March 12, 2026 5.0 868+ Votes Best Charlotte Personal Injury Attorney Ozempic / Semaglutide Gastroparesis Lawsuit: Charlotte NC Clients Charlotte-area patients who developed gastroparesis or severe GI injury after taking Ozempic, Wegovy, Mounjaro, or other GLP-1 drugs may have a products liability claim. Claims are in MDL 3094 in the E.D. Pa. A 2023 JAMA study found GLP-1 users had 9.09x the gastroparesis risk. Call (980) 239-2275. Key Takeaways: Ozempic / GLP-1 Gastroparesis GLP-1 agonists (Ozempic, Wegovy, Mounjaro, Zepbound) slow gastric emptying; in a subset of patients this causes severe, potentially permanent gastroparesis. A 2023 JAMA study (Sodhi et al.) found GLP-1 agonist users had 9.09x the risk of gastroparesis and 4.22x the risk of bowel obstruction. MDL 3094 is pending in the E.D. Pennsylvania, consolidating all GLP-1 agonist injury claims against Novo Nordisk and Eli Lilly under 28 U.S.C. § 1407. NC SOL: 3 years under N.C.G.S. § 1-52(16), discovery rule from when you connected your GI injury to the GLP-1 drug. Off-label weight-loss use is specifically evaluated – patients who took Ozempic for weight loss are included in the MDL plaintiff population. Free evaluation: Call (980) 239-2275. No fee unless your case resolves favorably. Why Trust Charlotte NC Car Accident Lawyers Group? 34+ Years Experience 1991 Established NC State Bar Licensed $0 Upfront Cost This resource was prepared by the attorneys at Charlotte NC Car Accident Lawyers Group to help NC patients understand GLP-1 agonist gastroparesis litigation and evaluate MDL 3094 claims. Awards: Voted Charlotte’s Best Personal Injury Law Firm – Gold Award 2024 and 2025 Written by: Steve Hayes, J.D. & Cameron Bauer, Esq. | Last Updated: March 12, 2026 Educational information only. Not legal advice. Past results do not guarantee future outcomes. Free Ozempic / GLP-1 Gastroparesis Case Evaluation (980) 239-2275 Phone lines answered 24/7 – No fee unless we win – Table of Contents What Is Ozempic / Semaglutide? The Science: GLP-1 Drugs and Gastroparesis MDL 3094: The Federal GLP-1 Litigation Who Qualifies? NC Statute of Limitations Damages Available Charlotte Context NC Law and Ozempic Claims How the Claim Process Works Authoritative Sources Frequently Asked Questions What Is Ozempic / Semaglutide and Why Are Patients Filing Lawsuits? Ozempic, Wegovy, and Rybelsus are brand names for semaglutide, a GLP-1 receptor agonist made by Novo Nordisk. Mounjaro and Zepbound (tirzepatide, Eli Lilly) are related drugs. Lawsuits allege manufacturers failed to warn that these medications can cause severe gastroparesis (stomach paralysis), intestinal obstruction, and ileus. GLP-1 receptor agonists slow gastric emptying as part of their glucose-regulating mechanism. In a subset of patients this slowing becomes severe and permanent. The core legal theory is failure to warn under N.C.G.S. § 99B-5: plaintiffs allege Novo Nordisk and Eli Lilly knew from clinical trial data that GLP-1 agonists caused severe gastroparesis at rates not disclosed on the product label, particularly for patients using these drugs for weight loss. Drug (Brand) Manufacturer Active Ingredient FDA Approval Ozempic Novo Nordisk Semaglutide Type 2 diabetes Wegovy Novo Nordisk Semaglutide (higher dose) Chronic weight management Rybelsus Novo Nordisk Semaglutide (oral) Type 2 diabetes Mounjaro Eli Lilly Tirzepatide Type 2 diabetes Zepbound Eli Lilly Tirzepatide Chronic weight management Gastroparesis and GLP-1 Drugs: The Science A landmark 2023 JAMA study (Sodhi et al., UBC) analyzed 16+ million patients and found GLP-1 agonist users had significantly elevated rates of gastroparesis, pancreatitis, and bowel obstruction. Condition Relative Risk (Sodhi et al., JAMA 2023) Gastroparesis 9.09x higher risk vs. bupropion-naltrexone group Bowel obstruction (ileus) 4.22x higher risk Pancreatitis Elevated, statistically significant Biliary disease Elevated risk The FDA updated Ozempic and Wegovy labels in 2023 to add ileus as a reported adverse event. Plaintiffs argue this was inadequate – gastroparesis, a more severe and often permanent condition, still lacks adequate label prominence. MDL 3094: The Federal Ozempic / GLP-1 Litigation GLP-1 agonist injury claims are consolidated in MDL No. 3094 in the Eastern District of Pennsylvania. MDL 3094 is one of the fastest-growing MDLs in the country. Under 28 U.S.C. § 1407, the JPML consolidated all GLP-1 agonist injury claims in the E.D. Pa. Pre-trial discovery and general causation proceedings are ongoing. No global settlement has been announced as of this writing. MDL 3094 is not a class action – each plaintiff has individual damages. See What Is a Mass Tort? NC Explained. Who Qualifies for an Ozempic / GLP-1 Lawsuit in NC? Patients prescribed Ozempic, Wegovy, Mounjaro, Zepbound, or related GLP-1 agonists who were diagnosed with gastroparesis, intestinal obstruction, or severe persistent GI injury may qualify. Eligibility Factor Guideline Drug Ozempic, Wegovy, Rybelsus (semaglutide); Mounjaro, Zepbound (tirzepatide); other GLP-1 agonists Diagnosis Gastroparesis confirmed by gastric emptying study; intestinal obstruction/ileus; severe chronic GI injury Treatment Hospitalization, NG tube, feeding tube, TPN, prokinetic medication, or gastric neurostimulator Use purpose Both diabetes management and off-label weight-loss use evaluated NC SOL 3 years under N.C.G.S. § 1-52(16), discovery rule Patients who took compounded semaglutide are evaluated case by case as those claims involve compounding pharmacy defendants. Call (980) 239-2275 to discuss your drug history. NC Statute of Limitations for Ozempic / GLP-1 Claims NC’s statute of limitations is 3 years under N.C.G.S. § 1-52(16) with the discovery rule. The clock starts when you knew or should have known your GI injury was caused by your GLP-1 drug. Under N.C.G.S. § 1-52(16), widespread media coverage of the Sodhi et al. 2023 JAMA study may have started many patients’ discovery clocks in mid-2023. NC’s 12-year repose under N.C.G.S. § 1-46.1 sets an outer limit from your last dose. File While Evidence Is Fresh Many Ozempic and Wegovy patients recently discontinued the drug. Medical records documenting the gastroparesis diagnosis and prescribing history are easier to obtain now. Do not wait. Damages Available in an Ozempic / GLP-1 Gastroparesis Lawsuit Recoverable damages include past and future medical expenses, lost income, pain and suffering, emotional distress, and permanent disability from a chronic gastroparesis condition. Category Ozempic / Gastroparesis Examples Medical – past GI specialist visits, gastric emptying study, hospitalization, NG tube, prokinetic drugs, endoscopy Medical – future Ongoing GI management, feeding tube care or TPN, gastric neurostimulator, lifelong nutritional support Lost income Wages lost during hospitalizations; disability from inability to maintain adequate nutrition Pain and suffering Chronic nausea, vomiting, abdominal pain, inability to eat normally Wrongful death N.C.G.S. § 28A-18-2 – if gastroparesis complications caused death Punitive damages available under N.C.G.S. Chapter 1D if Novo Nordisk or Eli Lilly acted with fraud or willful disregard for patient safety. Ozempic Use in Charlotte: Local Relevance Charlotte is a fast-growing metro with large populations managing Type 2 diabetes and obesity. Novant Health and Atrium Health physicians throughout Mecklenburg County have been high-volume GLP-1 prescribers since weight-loss use surged in 2021-2022. NC has an adult obesity rate above the national average. Charlotte-area primary care physicians and endocrinologists were early high-volume GLP-1 adopters, meaning Charlotte has a substantial potential plaintiff population. See also: NEC Baby Formula Lawsuit and CPAP / Philips Lawsuit. Authoritative Sources on Ozempic / GLP-1 Safety Sources used in preparing this page. JAMA: Sodhi et al. (2023) – GLP-1 Agonists and Risk of Adverse GI Events FDA: Ozempic Prescribing Information and Safety Updates IFFGD: Gastroparesis Patient Information N.C.G.S. Chapter 99B – NC Products Liability Act N.C.G.S. § 99B-5 – Failure to Warn N.C.G.S. § 1-52(16) – NC Statute of Limitations 28 U.S.C. § 1407 – MDL Consolidation Statute North Carolina Law and Ozempic / GLP-1 Claims: What You Need to Know North Carolina plaintiffs in mass tort litigation are protected by the NC Products Liability Act under N.C.G.S. Chapter 99B. Understanding how NC law intersects with federal MDL proceedings is essential for evaluating your claim. NC Legal Element How It Applies to Ozempic / GLP-1 Claims Products liability – failure to warn N.C.G.S. § 99B-5: manufacturer must warn of known risks not obvious to ordinary consumer Products liability – negligent design N.C.G.S. § 99B-6: product design must not render it unreasonably dangerous Statute of limitations 3 years from discovery under N.C.G.S. § 1-52(16). For many patients the discovery clock started when they connected their gastroparesis diagnosis to the GLP-1 drug, which for many patients was in 2023 with the JAMA study publication and extensive media coverage. Statute of repose 12 years under N.C.G.S. § 1-46.1. Runs from your last GLP-1 dose. For most recent Ozempic and Wegovy patients the repose is not an immediate concern, but the 3-year limitations clock is. Contributory negligence N.C.G.S. § 1-139: NC is a pure contributory negligence state – if plaintiff is even 1% at fault, recovery may be barred. Discuss with counsel. Punitive damages N.C.G.S. Chapter 1D: available for fraud, malice, or willful and wanton conduct. Capped at 3x compensatory damages or $250,000. Well-supported in Ozempic/Wegovy cases given evidence that Novo Nordisk and Eli Lilly had internal pharmacovigilance data showing gastroparesis risk and delayed adequate label disclosure. Wrongful death N.C.G.S. § 28A-18-2: available for families of decedents whose death resulted from the product injury MDL proceedings Filed in E.D. Pennsylvania under 28 U.S.C. § 1407 (MDL 3094). NC state law claims are asserted alongside federal claims; NC limitations still apply. Charlotte NC Car Accident Lawyers Group coordinates with national MDL co-counsel to ensure NC clients have both strong state law claims and are properly represented in the MDL pre-trial proceedings. Call (980) 239-2275 to discuss how NC law applies to your specific situation. How the Ozempic / GLP-1 Claim Process Works for Charlotte NC Clients Understanding the mass tort claim process helps you make informed decisions. Here is how Charlotte NC Car Accident Lawyers Group handles Ozempic / GLP-1 claims from initial evaluation through resolution. Step 1 – Free Evaluation: Call (980) 239-2275. Our intake team reviews your diagnosis, treatment history, and exposure/use history for Ozempic / GLP-1. Step 2 – Records Collection: We assist you in requesting medical records, prescription records, device records, or exposure documentation at no cost to you. Step 3 – Case Evaluation: Our attorneys and national MDL co-counsel review your records to evaluate the strength of your claim and applicable NC and federal law. Step 4 – Retention Agreement: If your claim qualifies, we provide a contingency fee agreement. You pay no attorney fee unless your case resolves favorably. Step 5 – MDL Filing: Your claim is filed in MDL 3094 in the E.D. Pa. Charlotte NC Car Accident Lawyers Group handles NC intake; national MDL co-counsel handle E.D. Pa. proceedings. Step 6 – Discovery: MDL plaintiffs participate in coordinated discovery. Your attorneys handle all discovery obligations. Step 7 – Settlement or Trial: If a settlement is negotiated, you individually review and decide whether to accept. If your case proceeds to trial, bellwether or individual trial proceedings apply. Step 8 – Resolution: Upon favorable resolution, attorney fees are deducted from the recovery per the contingency agreement. You receive the net recovery. There is no cost to you unless your case resolves favorably. Our contingency fee is disclosed transparently in your retention agreement, including the co-counsel fee sharing arrangement. Call (980) 239-2275 to start the process. Your Charlotte Ozempic / GLP-1 Gastroparesis Lawyers Steve Hayes, J.D. Founder and Managing Attorney Steve Hayes founded Charlotte NC Car Accident Lawyers Group in 1991 and has more than three decades of experience representing injured North Carolinians. He evaluates Charlotte-area patients for MDL 3094 GLP-1 gastroparesis claims and coordinates with national mass tort co-counsel. Education University of North Carolina at Greensboro – B.A. Campbell University School of Law – J.D. Bar Admissions North Carolina State Bar (NC Bar #18224) South Carolina Bar Memberships North Carolina State Bar South Carolina Bar North Carolina Bar Association American Bar Association North Carolina Advocates for Justice Mecklenburg County Bar Association Mecklenburg Medical Legal Society Cameron Bauer, Esq. Associate Attorney Cameron Bauer is an associate attorney at Charlotte NC Car Accident Lawyers Group, assisting with GLP-1 agonist gastroparesis intake evaluations and medical record coordination for Charlotte-area patients. Education University of South Carolina – B.A. Elon University School of Law – J.D. Bar Admissions North Carolina State Bar (NC Bar #63306) Memberships North Carolina State Bar American Bar Association Why Charlotte Residents Choose Us for Mass Tort Claims 34+ 34+ Years Protecting Charlotte Consumers Since 1991, our attorneys have represented injured North Carolinians against corporations and insurers. Voted Charlotte’s Best Personal Injury Law Firm – Gold Award 2024 and 2025. MDL National MDL Co-Counsel Network Mass tort MDL cases require attorneys who handle thousands of similar claims at the federal level. Our co-counsel partners are dedicated MDL litigators; you get their national resources while working with our Charlotte team. $0 Zero Upfront Cost – Contingency Fee You pay nothing to evaluate your Ozempic / GLP-1 Gastroparesis claim. Attorney fees are only collected if your case resolves in your favor. NC Local Counsel. Local Knowledge. Your case is evaluated by NC-licensed attorneys who know N.C.G.S. Chapter 99B products liability law and NC’s discovery rule and contributory negligence doctrine. 24/7 24/7 Case Evaluation Line Call (980) 239-2275 at any hour. You will speak with a member of our team – not a call center. Other Mass Tort Cases We Evaluate for Charlotte Clients What Is a Mass Tort? NC Explained Depo-Provera Brain Tumor Lawsuit CPAP Machine Recall Lawsuit NEC Baby Formula Lawsuit Paragard IUD Lawsuit View all 18 spokes on the Charlotte Mass Tort Lawyers hub. Frequently Asked Questions What is the Ozempic lawsuit about? The Ozempic lawsuit alleges that Novo Nordisk (Ozempic, Wegovy) and Eli Lilly (Mounjaro, Zepbound) failed to warn that GLP-1 receptor agonist medications can cause gastroparesis, intestinal obstruction, and severe GI injuries. Claims are consolidated in MDL 3094 in the Eastern District of Pennsylvania. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275. What is gastroparesis? Gastroparesis is a condition in which the stomach muscles fail to move food through the digestive tract normally, causing delayed gastric emptying. Symptoms include chronic nausea, vomiting, early satiety, abdominal pain, and malnutrition. Confirmed by a gastric emptying study. Severe cases may require feeding tubes or a gastric neurostimulator and can be permanent even after stopping the drug. Does the Ozempic lawsuit cover Wegovy and Mounjaro? Yes. MDL 3094 covers Ozempic, Wegovy, Rybelsus (semaglutide) and Mounjaro, Zepbound (tirzepatide) and other GLP-1 agonists. If you developed gastroparesis or severe GI injury on any of these drugs, your claim is evaluated for inclusion. MDL dockets evolve continuously; our team monitors case law developments, bellwether trial outcomes, and court orders that affect NC plaintiffs. What if I took Ozempic off-label for weight loss? Off-label weight-loss use is specifically evaluated in MDL 3094. Patients using GLP-1 drugs purely for weight loss received no diabetes benefit, making an adverse event like gastroparesis a particularly significant harm-to-benefit issue in the litigation. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275. What did the 2023 JAMA study find? Sodhi et al. (JAMA 2023) analyzed over 16 million patients and found GLP-1 agonist users had 9.09x the risk of gastroparesis and 4.22x the risk of bowel obstruction vs. users of bupropion-naltrexone. This study is central evidence in MDL 3094. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275. Has the FDA taken action on Ozempic safety? In 2023 the FDA updated Ozempic and Wegovy labels to add ileus as a reported adverse event. Plaintiffs argue this was inadequate – gastroparesis was not given sufficient label prominence, and the update came years after the drugs were widely prescribed. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275. Who qualifies for an Ozempic lawsuit? Patients prescribed a GLP-1 agonist who were diagnosed with gastroparesis confirmed by gastric emptying study, intestinal obstruction/ileus, or severe persistent GI injury requiring hospitalization, GI specialist care, or feeding tube / TPN. NC 3-year SOL under N.C.G.S. sec. 1-52(16) applies. Call (980) 239-2275. Charlotte-area residents can receive a free eligibility evaluation at no cost or obligation by calling (980) 239-2275. What is MDL 3094? MDL 3094 is pending in the E.D. Pennsylvania before Judge Gene E.K. Pratter. Under 28 U.S.C. sec. 1407, it consolidates all GLP-1 agonist injury claims against Novo Nordisk and Eli Lilly for coordinated pre-trial proceedings. It is not a class action. Each plaintiff maintains an individual case with individual damages evaluated separately – this is not a class action. How long do I have to file in North Carolina? 3 years under N.C.G.S. sec. 1-52(16), discovery rule from when you knew your GI injury was caused by the GLP-1 drug. 12-year repose under N.C.G.S. sec. 1-46.1 from last dose. North Carolina’s 3-year statute of limitations under N.C.G.S. § 1-52(16) runs from the discovery date, not the date of product use. The 12-year statute of repose under N.C.G.S. § 1-46.1 sets an outer limit from last product use. Does the lawsuit cover compounded semaglutide? Compounded semaglutide involves different defendants (compounding pharmacies, not Novo Nordisk) and is evaluated case by case. Contact our office to discuss your specific prescription history. MDL dockets evolve continuously; our team monitors case law developments, bellwether trial outcomes, and court orders that affect NC plaintiffs. Call (980) 239-2275 for the most current assessment of how recent developments may affect your specific claim. What damages can I recover? Past and future medical expenses, lost income, pain and suffering, emotional distress. Wrongful death under N.C.G.S. sec. 28A-18-2; punitive damages under N.C.G.S. Chapter 1D. Compensatory damages under N.C.G.S. Chapter 99B typically include medical expenses, lost wages, and non-economic harm such as pain and suffering. Punitive damages may be available under N.C.G.S. Chapter 1D when a manufacturer acted with willful disregard for consumer safety. Is gastroparesis always permanent after stopping Ozempic? Not always, but a significant subset of patients have persistent or permanent gastroparesis even after stopping the drug. Permanent gastroparesis significantly strengthens long-term damages. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275. There is no fee unless your case resolves favorably – our team handles everything on a contingency basis. Can I file if I still have gastroparesis after stopping? Yes. Persistent gastroparesis after stopping the drug strengthens your claim. The limitations clock starts when you connected your GI injury to the GLP-1 drug. Charlotte NC Car Accident Lawyers Group provides free, no-obligation evaluations for all mass tort claims at (980) 239-2275. There is no fee unless your case resolves favorably – our team handles everything on a contingency basis. What is the first step? Call (980) 239-2275 for a free confidential evaluation. Our team reviews your drug history and GI diagnosis. If your claim qualifies, we gather records at no cost. No fee unless your case resolves favorably. Call (980) 239-2275 for a free, no-obligation evaluation. Our team reviews your product use and diagnosis history at no cost. Is this a class action? No. MDL 3094 is a mass tort. Each plaintiff has individual damages. You decide individually whether to accept any settlement offer. In a mass tort, your damages – medical costs, lost income, pain and suffering – are evaluated individually based on your specific injury and history. You independently decide whether to accept any settlement offer; no group vote or representative plaintiff makes that decision for you. What NC law applies? N.C.G.S. Chapter 99B (products liability), sec. 99B-5 (failure to warn), sec. 99B-6 (negligent design). NC 3-year limitations (sec. 1-52(16)), 12-year repose (sec. 1-46.1), contributory negligence (sec. 1-139). North Carolina’s Products Liability Act (Chapter 99B) governs failure-to-warn and defective design claims filed in NC state court. Federal MDL dockets apply federal procedural rules, but NC substantive law governs your claims when they return to your home district for trial. Do I need to travel to Pennsylvania? No. Our Charlotte office handles local intake and NC law. National MDL co-counsel handle E.D. Pa. proceedings. You participate locally. MDL proceedings are handled federally by co-counsel; most Charlotte-area plaintiffs never appear in the MDL court. Some depositions may be conducted remotely; our team coordinates all procedural requirements so you can focus on your recovery. How does co-counsel work? Charlotte NC Car Accident Lawyers Group handles intake, records, and NC law. National MDL co-counsel handle MDL 3094 federal proceedings. Fee is shared – you pay no more because two firms are involved. The co-counsel arrangement is fully disclosed in your retainer and compliant with NC State Bar rules on fee-sharing. Total attorney fees are split between the two firms based on work performed; you pay no higher fee because two firms are involved. Can family members file if a loved one died? Yes. Under N.C.G.S. sec. 28A-18-2 the estate may pursue wrongful death if Ozempic-related complications caused death. Contact our office promptly – limitations apply. Wrongful death claims in North Carolina are governed by N.C.G.S. § 28A-18-2 and must be filed by the appointed estate administrator. Surviving family members may recover economic losses, loss of companionship, and other damages depending on the circumstances of the death. Related Practice Areas Wrongful Death Catastrophic Injury Medical Malpractice Personal Injury Workers Compensation Visit Our Charlotte Office – Ozempic Lawsuit Charlotte Nc Gastroparesis Ozempic lawsuit Charlotte NC gastroparesis Charlotte NC 7421 Carmel Executive Park Drive, Suite 212, Charlotte, NC 28226 | (980) 239-2275 Contact Our Charlotte Ozempic / GLP-1 Gastroparesis Lawyers Free Ozempic / GLP-1 Gastroparesis Case Evaluation We evaluate Charlotte-area clients on a contingency fee basis – no fee unless your case resolves favorably. Our co-counsel MDL partners handle federal litigation while we remain your Charlotte point of contact. (980) 239-2275 Contact Us Online | 7421 Carmel Executive Park Drive, Suite 212, Charlotte, NC 28226 Disclaimer: Educational purposes only. Not legal advice. No attorney-client relationship formed. Mass tort cases are complex and fact-specific – outcomes depend on the unique circumstances of each case. Past results do not guarantee future outcomes. © 2026 Charlotte NC Car Accident Lawyers Group. All rights reserved. | Privacy Policy Related GuidesBack to Charlotte Mass Tort Lawyers.Hair Relaxer Cancer Lawsuit Charlotte NC | Uterine Cancer LawyersHernia Mesh Lawsuit Charlotte NC | Revision Surgery LawyersMesothelioma Asbestos Lawsuit Charlotte NC | Asbestos Cancer LawyersNEC Baby Formula Lawsuit Charlotte NC | Similac Enfamil LawyersParagard IUD Lawsuit Charlotte NC | Fracture Injury LawyersPhilips CPAP Recall Lawsuit Charlotte NC | Cancer Injury LawyersRoundup Cancer Lawsuit Charlotte NC | Non-Hodgkin’s Lymphoma LawyersSocial Media Addiction Lawsuit Charlotte NC | Instagram TikTok Teen Lawyers
2 Ozempic / Semaglutide Gastroparesis Lawsuit: Charlotte NC Clients
wpChatIcon
wpChatIcon
Visit Us On TwitterVisit Us On FacebookVisit Us On YoutubeCheck Our Feed